Centocor Inc.'s stock (NASDAQ:CNTO) rose $1.25 a shareWednesday on busy trading of about 1.8 million shares.Analyst Wole Fayemi of Hambrecht & Quist in New Yorkupgraded his rating on the Malvern, Pa.-based company from a"speculative buy" to a "buy." Fayemi said he expects significantadvances in product development over the course of 1993 andthat the company's financial position continues to improve as itlowers its burn rate and revises its business strategy.

(c) 1997 American Health Consultants. All rights reserved.